• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

GRAS Notices

  • Print
  • Share
  • E-mail

GRN No. 423

Cow's milk-derived lactoferrin

Intended Use: Use as an ingredient in cow's milk-based term infant formulas at a level of 13 milligram per 100 milliliter (mg/mL) formula (ready-to-feed or prepared from powder or concentrate) and in other cow's milk-based products including yogurts (100 mg per 100 gram (g)), powdered milk (400 mg/100 g), and milk-based frozen desserts (200 mg/100 g), and in chewing gum (30 mg/g)
Basis: Scientific procedures
Notifier: Morinaga Milk Industry Co., Ltd
Notifier Address: 33-1, Shiba 5-Chome, Minato-ku,
Tokyo 108-8384
Date of filing: Mar 7, 2012
GRAS Notice (releasable information): GRN 423 (in PDF) (8.0 MB)
Date of closure: May 2, 2012
FDA's Letter: At notifier's request, FDA ceased to evaluate the notice